10 Jun
2021

Post-Brexit, the UK is poised to become a global biosimilars hotspot

The UK is emerging as a jurisdiction of choice for biosimilars. But, writes Claire Phipps-Jones of Bristows, alongside the opportunities there are potential pitfalls to be aware of

Claire Phipps-Jones

Senior associate | Bristows

London, UK